Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy.

MLA

Sloane, Evan, et al. “Anti-Inflammatory Cytokine Gene Therapy Decreases Sensory and Motor Dysfunction in Experimental Multiple Sclerosis: MOG-EAE Behavioral and Anatomical Symptom Treatment with Cytokine Gene Therapy.” Brain, Behavior, and Immunity, vol. 23, no. 1, Jan. 2009, pp. 92–100. EBSCOhost, https://doi.org/10.1016/j.bbi.2008.09.004.

APA

Sloane, E., Ledeboer, A., Seibert, W., Coats, B., van Strien, M., Maier, S. F., Johnson, K. W., Chavez, R., Watkins, L. R., Leinwand, L., Milligan, E. D., & Van Dam, A. M. (2009). Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain, Behavior, and Immunity, 23(1), 92–100. https://doi.org/10.1016/j.bbi.2008.09.004

Chicago

Sloane, Evan, A Ledeboer, W Seibert, B Coats, M van Strien, S F Maier, K W Johnson, et al. 2009. “Anti-Inflammatory Cytokine Gene Therapy Decreases Sensory and Motor Dysfunction in Experimental Multiple Sclerosis: MOG-EAE Behavioral and Anatomical Symptom Treatment with Cytokine Gene Therapy.” Brain, Behavior, and Immunity 23 (1): 92–100. doi:10.1016/j.bbi.2008.09.004.